Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Should statin therapy be allocated on the basis of global risk or on the basis of randomized trial evidence?

DeMazumder D, Hasan RK, Blumenthal RS, Michos ED, Jones S.

Am J Cardiol. 2010 Sep 15;106(6):905-9. doi: 10.1016/j.amjcard.2010.05.015.

2.

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.

Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ; Coordinating Committee of the National Cholesterol Education Program.

J Am Coll Cardiol. 2004 Aug 4;44(3):720-32. Review.

PMID:
15358046
3.

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.

Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ; Coordinating Committee of the National Cholesterol Education Program.

Arterioscler Thromb Vasc Biol. 2004 Aug;24(8):e149-61. Review.

4.

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.

Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ; National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association.

Circulation. 2004 Jul 13;110(2):227-39. Review. Erratum in: Circulation. 2004 Aug 10;110(6):763.

5.

A proposal to incorporate trial data into a hybrid ACC/AHA algorithm for the allocation of statin therapy in primary prevention.

Ridker PM, Rose L, Cook NR.

J Am Coll Cardiol. 2015 Mar 10;65(9):942-8. doi: 10.1016/j.jacc.2014.12.028. Review.

6.

A trial-based approach to statin guidelines.

Ridker PM, Wilson PW.

JAMA. 2013 Sep 18;310(11):1123-4. doi: 10.1001/jama.2013.276529. No abstract available.

PMID:
23942579
7.

Use and monitoring of "statin" lipid-lowering drugs compared with guidelines.

Abookire SA, Karson AS, Fiskio J, Bates DW.

Arch Intern Med. 2001 Jan 8;161(1):53-8.

PMID:
11146698
9.

Results of new statin trials: should the low-density lipoprotein cholesterol treatment guidelines be revised?

Ross AM, Ganiats TG.

Curr Atheroscler Rep. 2005 Feb;7(1):11-6. Review.

PMID:
15683596
10.
11.

An evidence-based assessment of the NCEP Adult Treatment Panel II guidelines. National Cholesterol Education Program.

Ansell BJ, Watson KE, Fogelman AM.

JAMA. 1999 Dec 1;282(21):2051-7. Review.

PMID:
10591388
12.
13.

Cholesterol management and the reduction of cardiovascular risk.

Nixon JV.

Prev Cardiol. 2004 Winter;7(1):34-9; quiz 40-1. Review.

14.

Application of new cholesterol guidelines to a population-based sample.

Pencina MJ, Navar-Boggan AM, D'Agostino RB Sr, Williams K, Neely B, Sniderman AD, Peterson ED.

N Engl J Med. 2014 Apr 10;370(15):1422-31. doi: 10.1056/NEJMoa1315665. Epub 2014 Mar 19.

15.

Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.

Evans M, Roberts A, Davies S, Rees A.

Drugs. 2004;64(11):1181-96. Review.

PMID:
15161326
16.
17.

Dyslipidemia: management using optimal lipid-lowering therapy.

Ito MK.

Ann Pharmacother. 2012 Oct;46(10):1368-81. doi: 10.1345/aph.1R127. Epub 2012 Oct 2. Review.

PMID:
23032652
18.

Cardiovascular risk reduction: what do recent trials with rosuvastatin tell us?

Fabbri G, Maggioni AP.

Adv Ther. 2009 May;26(5):469-87. doi: 10.1007/s12325-009-0025-6. Epub 2009 May 14. Review.

PMID:
19444394
19.

Statin treatment and adherence to national cholesterol guidelines after ischemic stroke.

Ovbiagele B, Saver JL, Bang H, Chambless LE, Nassief A, Minuk J, Toole JF, Crouse JR; VISP Study Investigators.

Neurology. 2006 Apr 25;66(8):1164-70.

PMID:
16636231
20.

Recent National Cholesterol Education Program Adult Treatment Panel III update: adjustments and options.

Stone NJ, Bilek S, Rosenbaum S.

Am J Cardiol. 2005 Aug 22;96(4A):53E-59E. Review.

PMID:
16098845

Supplemental Content

Support Center